QE-HF replacement - Proteomics and Non-targeted Analysis

The contract involves replacing two outdated Human Resource Management Systems (HRMS) that have been in use for over a decade and are no longer operationally effective. The new system will deliver advanced proteomics data capabilities to support research projects focused on New Approach Methodologies (NAMs) as well as other vital analytical applications. This upgrade is critical to enhancing the Food and Drug Administration's (FDA) ability to conduct sophisticated data analysis essential for current and future scientific investigations. The contract, titled "QE-HF replacement - Proteomics and Non-targeted Analysis," is forecasted under the NAICS code 541990 and has been posted as of March 11, 2026. It is managed by the FDA, with key contacts including a program point of contact accessible via email and a contracting officer yet to be designated. The scope and specific location details of performance are not specified, but the opportunity is publicly available for industry consideration through the FDA’s acquisition office.